CSIMarket
 


Quidel Corporation  (QDEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


Quidel's EBITDA Margin by quarter

Trends, Rankings, Statistics



QDEL EBITDA Margin (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Revenue Change -12.46 % 114.9 % 431.75 % 276.35 % 86.37 %
Seq. Revenue Change -52.95 % -53.62 % 69.98 % 135.96 % 15.52 %
Revenue In Millions $176.61 $375.34 $809.20 $476.06 $201.75
EBITDA Margin 21.46 % 63.14 % 78.14 % 65.15 % 47.47 %
EBITDA Margin Total Ranking # 1586 # 361 # 301 # 356 # 625
EBITDA In Millions $37.89 $237.00 $632.35 $310.17 $95.77
Y / Y EBITDA Change -60.43 % 285.24 % 1816.9 % 834.82 % 428.91 %
Seq. EBITDA Change -84.01 % -62.52 % 103.87 % 223.89 % 55.67 %


Commenting Second Quarter 2021 EBITDA Margin
Quidel Corporation experienced contraction in EBITDA by -84.01 % to $177 millions and Revenue by -52.95 %, while EBITDA Margin fell to 21.46 %, below company's average EBITDA Margin.

Observing second quarter 2021 results within Biotechnology & Drugs industry 18 other companies have achieved higher EBITDA Margin. While EBITDA Margin overall ranking has deteriorated compare to previous quarter from 361 to 1586.
Learn about Operating Margin
QDEL's EBITDA Margin second quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 19
Healthcare Sector # 120
Overall # 1586

EBITDA Margin Statistics
High Average Low
78.14 % 27.51 % 2.5 %
(Dec 31 2020)   (Jun 30 2012)




Other EBITDA Margin Profitability Ratios
QDEL's Cumulative EBITDA Margin
Biotechnology & Drugs Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
QDEL's EBITDA Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for QDEL's Competitors
EBITDA Margin Profit Margin for Quidel's Suppliers
EBITDA Margin Profit Margin for QDEL's Customers

You may also want to know
QDEL's Annual Growth Rates QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's EBITDA Growth
QDEL's Roa QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Jun 30 2021, within Biotechnology & Drugs Industry EBITDA MarginJun 30 2021 MRQ EBITDAJun 30 2021 MRQ Revenue
Iterum Therapeutics Plc  49.20 %$ 7.770 $ 15.794 
Amyris Inc   47.06 %$ 24.621 $ 52.316 
Gilead Sciences Inc   41.69 %$ 2,592.000 $ 6,217.000 
Repligen Corp  36.41 %$ 59.340 $ 162.960 
Vir Biotechnology Inc   35.73 %$ 63.268 $ 177.068 
Meridian Bioscience Inc   30.68 %$ 19.486 $ 63.511 
Tarsus Pharmaceuticals Inc   29.29 %$ 6.448 $ 22.017 
Abbvie Inc   28.43 %$ 3,969.000 $ 13,959.000 
Cidara Therapeutics Inc   27.18 %$ 8.932 $ 32.863 
La Jolla Pharmaceutical Company  26.20 %$ 4.208 $ 16.059 
Neurocrine Biosciences Inc   24.44 %$ 70.600 $ 288.900 
Biogen Inc   23.60 %$ 655.000 $ 2,775.000 
Ortho Clinical Diagnostics Holdings Plc  22.98 %$ 113.200 $ 492.500 
Quidel Corporation  21.46 %$ 37.893 $ 176.610 
Neogen Corp  21.37 %$ 27.233 $ 127.425 
Twinlab Consolidated Holdings Inc   19.54 %$ 3.539 $ 18.109 
Avantor Inc   19.15 %$ 355.900 $ 1,858.600 
Integrated Biopharma Inc  18.00 %$ 3.071 $ 17.058 
Bio techne Corp  17.66 %$ 45.738 $ 259.028 
Reynolds Consumer Products Inc   16.49 %$ 144.000 $ 873.000 
Skinvisible Inc   13.78 %$ 0.040 $ 0.287 
Emergent Biosolutions Inc   12.58 %$ 50.000 $ 397.500 
Cyanotech Corp  11.56 %$ 1.036 $ 8.964 
Skinovation Pharmaceutical Inc  10.09 %$ 6.710 $ 66.508 
Myriad Genetics Inc   7.97 %$ 15.100 $ 189.400 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EAC's Profile

Stock Price

EAC's Financials

Business Description

Fundamentals

Charts & Quotes

EAC's News

Suppliers

EAC's Competitors

Customers & Markets

Economic Indicators

EAC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071